Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin plus hyaluronic acid for chin augmentation in class II malocclusion
RBR-4435k8wTerminated
- Sponsor
- Uningá
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in class II malocclusion comparing Botulinum toxin + hyaluronic acid with Saline + hyaluronic acid control (2 arms). Primary endpoint: Efficacy of chin augmentation. Started Aug 2024; status: terminated.
02
Drugs
neuronoxhyaluronic acidsaline
03
Conditions
class II malocclusion
Beyond the preview
Go deeper on RBR-4435k8w.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4435k8w.